Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Muramyl peptides. Chemical structure, biological activity and mechanism of action.

× No keyword cloud information.

130 in total

Review 1. Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.

Authors: L Chedid; F Audibert; A G Johnson
Journal: Prog Allergy Date: 1978

Review 2. A guinea pig model for tumor immunology. A summary.

Authors: H J Rapp
Journal: Isr J Med Sci Date: 1973-03

3. Influence of MDP and of some analogous synthetic glycopeptides on the in vitro mouse spleen cell viability and immune response to sheep erythrocytes.

Authors: C Leclerc; I Löwy; L Chedid
Journal: Cell Immunol Date: 1978-07 Impact factor: 4.868

4. Synthesis of N-acetyl-6-amino- and -6-(acylamino)-6-deoxymuramoyl dipeptides, and their immunoadjuvant activities.

Authors: A Hasegawa; H Okumura; M Kiso; I Azuma; Y Yamamura
Journal: Carbohydr Res Date: 1980-02 Impact factor: 2.104

5. Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs.

Authors: M Uemiya; K Sugimura; T Kusama; I Saiki; M Yamawaki; I Azuma; Y Yamamura
Journal: Infect Immun Date: 1979-04 Impact factor: 3.441

6. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-L-alanyl-D-isoglutamine.

Authors: Y Yamamura; I Azuma; K Sugimura; M Yamawaki; M Uemiya
Journal: Gan Date: 1976-12

7. Separation of a water-soluble adjuvant (MAF3) from delipidated cells of Mycobacterium tuberculosis strain Aoyama B by hydrogenolysis and gel filtration.

Authors: Y Kumazawa; A Shibusawa; T Suzuki; K Mizunoe
Journal: Jpn J Microbiol Date: 1976-06

8. Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.

Authors: I Azuma; K Sugimura; T Taniyama; M Yamawaki; Y Yamamura
Journal: Infect Immun Date: 1976-07 Impact factor: 3.441

9. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.

Authors: C A Dinarello; R J Elin; L Chedid; S M Wolff
Journal: J Infect Dis Date: 1978-12 Impact factor: 5.226

10. Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.

Authors: E Yarkoni; H J Rapp
Journal: Infect Immun Date: 1980-06 Impact factor: 3.441

26 in total

Review 1. Endogenous synthesis of peptidoglycan in eukaryotic cells; a novel concept involving its essential role in cell division, tumor formation and the biological clock.

Authors: C A Roten; D Karamata
Journal: Experientia Date: 1992-10-15

2. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination.

Authors: Michael de Vrese; Peter Rautenberg; Christiane Laue; Marion Koopmans; Tineke Herremans; Jürgen Schrezenmeir
Journal: Eur J Nutr Date: 2004-12-01 Impact factor: 5.614

Review 3. NLR proteins: integral members of innate immunity and mediators of inflammatory diseases.

Authors: Jeanette M Wilmanski; Tanja Petnicki-Ocwieja; Koichi S Kobayashi
Journal: J Leukoc Biol Date: 2007-09-17 Impact factor: 4.962

4. Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs.

Authors: R J Ho; R L Burke; T C Merigan
Journal: J Virol Date: 1989-07 Impact factor: 5.103

5. A study on the rat brain receptors for tachykinins and muramyl peptides.

Authors: E M Lazakovich; A A Kaydalov; I E Kasheverov; V I Tsetlin
Journal: J Protein Chem Date: 1989-06

6. Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice.

Authors: J A Montaraz; A J Winter
Journal: Infect Immun Date: 1986-08 Impact factor: 3.441

7. Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy.

Authors: Chikako Ogawa; Yuen-Joyce Liu; Koichi S Kobayashi
Journal: Curr Bioact Compd Date: 2011-09

8. Enhancement of dengue virus type 2 replication in mouse macrophage cultures by bacterial cell walls, peptidoglycans, and a polymer of peptidoglycan subunits.

Authors: H Hotta; S Hotta; H Takada; S Kotani; S Tanaka; M Ohki
Journal: Infect Immun Date: 1983-08 Impact factor: 3.441

9. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2.

Authors: Lilian O Moreira; Amber M Smith; Ashley A DeFreitas; Joseph E Qualls; Karim C El Kasmi; Peter J Murray
Journal: Vaccine Date: 2008-09-27 Impact factor: 3.641

10. Immunotherapy of Lewis lung carcinoma with hydrosoluble peptidoglycan monomer (PGM).

Authors: G Sava; T Giraldi; J Tomasić; I Hrsak
Journal: Cancer Immunol Immunother Date: 1983 Impact factor: 6.968